Oric Pharmaceuticals, Inc. Common Stock
XNAS:ORIC
11.5
$12.13 - 27.00
$9.45 - 150.00
$11.05
$11.78
$11.65
$11.88
14.93
3.9
1141056
1267800.5
54156047.17
Chart
TendieTensor AI Analysis
Company
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Fundamentals
128
-6.440000
2.665520
-0.33
100
BBG00BL5SLH5
BBG00BL5SMR2
97.12M
97.12M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ORIC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.